SIREN : 333870087
DKD MEDICAL is a French company founded 40 years ago, specialized in the sector Fabrication de matériel médico-chirurgical et dentaire. Based in VILLEVIEILLE (30250), this company of category PME shows in 2024 a revenue of 1.4 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 396 610 € | 1 437 146 € | 1 358 102 € | 1 213 179 € | 1 764 382 € | 1 138 941 € | 1 309 885 € | 1 432 809 € | 1 407 441 € |
| Net income | -171 283 € | -11 293 € | -55 961 € | -267 559 € | 56 346 € | -102 020 € | 15 950 € | -124 574 € | -132 419 € |
| EBITDA | -164 162 € | -15 809 € | -82 227 € | -316 977 € | 51 624 € | -106 668 € | 19 823 € | 33 923 € | -64 069 € |
| Net margin | -12.3% | -0.8% | -4.1% | -22.1% | 3.2% | -9.0% | 1.2% | -8.7% | -9.4% |
In 2024, DKD MEDICAL achieves revenue of 1.4 M€. Activity remains stable over the period (CAGR: -0.1%). Slight decline of -3% vs 2023. After deducting consumption (622 k€), gross margin stands at 775 k€, i.e. a rate of 55%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -164 k€, representing -11.8% of revenue. Warning negative scissor effect: despite revenue change (-3%), EBITDA varies by -938%, reducing margin by 10.7 pts. This reflects costs rising faster than revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Net income is negative at -171 k€ (-12.3% of revenue), which will impact equity.
1 396 610 €
774 520 €
-164 162 €
-178 773 €
-171 283 €
-11.8%
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 63%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
0.053%
63.087%
-11.395%
-0.002
8.1%
In 2024, the debt ratio of DKD MEDICAL (0.05) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2024, the financial autonomy of DKD MEDICAL (63.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2024, the repayment capacity of DKD MEDICAL (-0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 261.60. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
261.595
0.0
In 2024, the liquidity ratio of DKD MEDICAL (261.60) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2024, the interest coverage of DKD MEDICAL (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 113 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 126 days. Favorable situation: supplier credit is longer than customer credit by 13 days. Inventory turnover is 126 days (= Average inventory / Cost of goods x 360). This high level ties up cash and potentially creates obsolescence risk. Overall, WCR represents 232 days of revenue, i.e. 901 k€ to permanently finance.
901 288 €
113 j
126 j
126 j
232 j
Based on 57 transactions of similar company sales
(all years),
the value of DKD MEDICAL is estimated at
316 751 €
(range 147 210€ - 662 749€).
The price/revenue ratio is 0.23x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 57 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare DKD MEDICAL with other companies in the same sector:
Voir toutes les statistiques du secteur Fabrication de matériel médico-chirurgical et dentaire
The revenue of DKD MEDICAL in 2024 is 1.4 M€.
DKD MEDICAL recorded a net loss in 2024.
The headquarters of DKD MEDICAL is located in VILLEVIEILLE (30250), in the department Gard.
The tax return of DKD MEDICAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
DKD MEDICAL operates in the sector Fabrication de matériel médico-chirurgical et dentaire (NAF code 32.50A). See the 'Sector positioning' section above to compare the company with its competitors.